The introduction of drugs containing tumor necrosis factor-alpha (TNF-α) inhibitors has revolutionized treatments for many inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease [1]. The gene discussed is TNF; the disease is inflammatory bowel disease.